115 related articles for article (PubMed ID: 6124550)
1. Quantitative determination of the beta-adrenoceptor stimulant formoterol in urine by gas chromatography mass spectrometry.
Kamimura H; Sasaki H; Higuchi S; Shiobara Y
J Chromatogr; 1982 May; 229(2):337-45. PubMed ID: 6124550
[TBL] [Abstract][Full Text] [Related]
2. The development of a radioimmunoassay for formoterol.
Yokoi K; Murase K; Shiobara Y
Life Sci; 1983 Oct; 33(17):1665-72. PubMed ID: 6138697
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of formoterol fumarate, a new bronchodilator, in rats and dogs.
Sasaki H; Kamimura H; Shiobara Y; Esumi Y; Takaichi M; Yokoshima T
Xenobiotica; 1982 Dec; 12(12):803-12. PubMed ID: 7170790
[TBL] [Abstract][Full Text] [Related]
4. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.
Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
Drug Test Anal; 2012 Jun; 4(6):449-54. PubMed ID: 22447497
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human.
Zhang M; Fawcett JP; Shaw JP
Br J Clin Pharmacol; 2002 Sep; 54(3):246-50. PubMed ID: 12236843
[TBL] [Abstract][Full Text] [Related]
6. Determination of formoterol in rat plasma by liquid chromatography-electrospray ionisation mass spectrometry.
Kakubari I; Dejima H; Miura K; Koga Y; Mizu H; Takayasu T; Yamauchi H; Takayama S; Takayama K
Pharmazie; 2007 Feb; 62(2):94-5. PubMed ID: 17341025
[TBL] [Abstract][Full Text] [Related]
7. The metabolism of salbutamol in man.
Evans ME; Walker SR; Brittain RT; Paterson JW
Xenobiotica; 1973 Feb; 3(2):113-20. PubMed ID: 4146095
[No Abstract] [Full Text] [Related]
8. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
[TBL] [Abstract][Full Text] [Related]
9. Optimization and validation of a gas chromatographic method for analysis of (RS,SR)-diastereoisomeric impurity in formoterol fumarate.
Akapo SO; Wegner M; Mamangun A; McCrea C; Asif M; Dussex JC
J Chromatogr A; 2004 Aug; 1045(1-2):211-6. PubMed ID: 15378897
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine.
Sardela VF; Deventer K; Pereira HM; de Aquino Neto FR; Van Eenoo P
J Pharm Biomed Anal; 2012 Nov; 70():471-5. PubMed ID: 22841556
[TBL] [Abstract][Full Text] [Related]
11. First high-performance liquid chromatography assay of formoterol concentrations in the low-picogram-per-milliliter range.
van den Berg BT; Portier EJ; van den Berg M; Braat MC; van Boxtel CJ
Ther Drug Monit; 1994 Apr; 16(2):196-9. PubMed ID: 7912013
[TBL] [Abstract][Full Text] [Related]
12. Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.
Garcia P; Paris AC; Gil J; Popot MA; Bonnaire Y
Biomed Chromatogr; 2011 Jan; 25(1-2):147-54. PubMed ID: 21204111
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of trimetoquinol in plasma as its mixed pentafluoropropionyl-trimethylsilyl derivative by gas chromatography mass spectrometry.
Suzuki T; Tsuzurahara K; Murata T; Takeyama S
Biomed Mass Spectrom; 1982 Mar; 9(3):94-8. PubMed ID: 7066482
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective glucuronidation of formoterol by human liver microsomes.
Zhang M; Fawcett JP; Kennedy JM; Shaw JP
Br J Clin Pharmacol; 2000 Feb; 49(2):152-7. PubMed ID: 10671910
[TBL] [Abstract][Full Text] [Related]
16. Determination of the alpha, beta-adrenoceptor blocker YM-09538 in urine by gas chromatography with a nitrogen-sensitive detector.
Kamimura H; Sasaki H; Kawamura S; Shimizu M; Matsumoto H; Kobayashi Y
J Chromatogr; 1983 Jun; 275(1):81-7. PubMed ID: 6135704
[TBL] [Abstract][Full Text] [Related]
17. Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.
Nadarassan DK; Chrystyn H; Clark BJ; Assi KH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):31-7. PubMed ID: 17126087
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography.
Visser TJ; van Waarde A; Doze P; Elsinga PH; van der Mark TW; Kraan J; Ensing K; Vaalburg W
Eur J Pharmacol; 1998 Nov; 361(1):35-41. PubMed ID: 9851539
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
20. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
